Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PepGen Inc. - Common Stock
(NQ:
PEPG
)
1.760
-0.020 (-1.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PepGen Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
PepGen to Participate in Upcoming Investor Conferences
March 04, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
March 04, 2025
From
PepGen Inc.
Via
Business Wire
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week
↗
March 02, 2025
New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025.
Via
Stocktwits
These stocks have an unusual volume in today's session
↗
February 28, 2025
Volume analysis on 2025-02-28: stocks with an unusual volume in today's session.
Via
Chartmill
What's Driving the Market Sentiment Around PepGen?
↗
February 25, 2025
Via
Benzinga
Why PepGen (PEPG) Stock Is Skyrocketing Today
↗
February 24, 2025
PepGen shares are trading higher by 90% during Monday's session. The company announced early data from its FREEDOM-DM1 trial for myotonic dystrophy.
Via
Benzinga
PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz?
↗
February 28, 2025
The rally follows PepGen's release of early clinical data from its Phase 1 trial evaluating its therapy to treat a rare genetic disorder.
Via
Stocktwits
These stocks are moving in today's after hours session
↗
February 27, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
Which stocks are experiencing notable movement on Thursday?
↗
February 27, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via
Chartmill
Which stocks are moving on Thursday?
↗
February 27, 2025
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Top movers in Monday's session
↗
February 24, 2025
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
These stocks are making the most noise in today's session.
↗
February 24, 2025
Let's dive into the action on the US markets on Monday. Here are the most active stocks that are driving the market today.
Via
Chartmill
These stocks are moving in today's session
↗
February 24, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
February 24, 2025
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights
February 24, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
February 24, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Announces CONNECT Program Updates
January 29, 2025
From
PepGen Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 16, 2024
Via
Benzinga
PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy
December 16, 2024
From
PepGen Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 03, 2024
Via
Benzinga
PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
November 21, 2024
From
PepGen Inc.
Via
Business Wire
Roku To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday
↗
November 18, 2024
Via
Benzinga
PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
November 07, 2024
From
PepGen Inc.
Via
Business Wire
PepGen to Participate in Upcoming Investor Conferences
November 04, 2024
From
PepGen Inc.
Via
Business Wire
PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society
October 08, 2024
From
PepGen Inc.
Via
Business Wire
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
September 30, 2024
Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathy
Via
MarketBeat
PepGen Announces Christopher Ashton, PhD, to Retire from its Board of Directors
September 19, 2024
From
PepGen Inc.
Via
Business Wire
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development
August 20, 2024
From
PepGen Inc.
Via
Business Wire
PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development
August 20, 2024
From
PepGen Inc.
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
